InvestorsHub Logo
Followers 58
Posts 727
Boards Moderated 1
Alias Born 10/30/2010

Re: $heff post# 78546

Wednesday, 04/23/2014 9:53:09 AM

Wednesday, April 23, 2014 9:53:09 AM

Post# of 97237
$SPPI $7.01 Sold a tranche on the gap up at the open

Spectrum Pharmaceuticals (Nasdaq: SPPI) announced that its pivotal trial of Captisol-enabled (propylene glycol-free) Melphalan met its primary end points.

PDUFA August 9, 2014, Priority Review, $9-10 target

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.